Abstract
Dyslipidemia is one of the known risk factors for cardiovascular disease, and its prevalence is increasing worldwide. At present, the study of dyslipidemia has gradually shifted from simple environmental or genetic factors to environment-gene interactions. In order to further explore the etiology and mechanism of dyslipidemia, we used occupational stress(OS) and LYPLAL1, APOC3 and SOD2 gene as research variables to explore their association with dyslipidemia.Here we used a case-control study to include Han workers from a coal mining enterprise in China to determine the association between study variables and dyslipidemia. Monofactor analysis showed that smoking, drinking, physical activity level, DASH diet score, sleep quality, BMI, hypertension, hyperuricemia, shift work, OS were significantly different between the two groups (P < 0.05). In the APOC3 rs2854116 dominant model, patients with CT/CC genotype had a higher risk of dyslipidemia than those with TT genotype. In SOD2 rs4880 recessive model, patients with GG genotype had a lower risk of dyslipidemia than those with AA/AG genotype, and the difference was statistically significant. We found that rs12137855 and OS, rs2854116 and OS, rs4880 and OS had joint effects, but no interaction based on the multiplication and addition model was found (Pinteraction > 0.05). GMDR model showed that the rs12137855-rs2854116-rs4880-OS four-factor model had the highest cross-validation consistency and training-validation accuracy (P < 0.05), suggesting that there was a high-order interaction between them associated with dyslipidemia. We found that dyslipidemia in coal miners was related to OS and genetic factors. Through this study, we revealed the dual regulation of environmental factors and genetic factors on dyslipidemia. At the same time, this study provides clues for understanding the etiology and mechanism of dyslipidemia.
Similar content being viewed by others
Introduction
Metabolic syndrome is a global public health problem, and atherosclerosis is one of its typical symptoms. According to statistics, 80% of atherosclerosis is caused by dyslipidemia1,2. And atherosclerosis is closely related to the development of cardiovascular diseases3. The prevalence of dyslipidemia in Chinese adults has been increasing year by year4, and this phenomenon deserves attention and in-depth study.
Studies have shown an association between the level of lipid metabolism in the body and psychological stress5. According to statistics, more than 60% of the American professional believes that the main source of stress is work, and more than 40% of people feel stressed and anxious at work6. In addition to age, gender, and environmental factors such as smoking, alcohol, diet, and mental health5,7,8,9, the body's lipid levels are also regulated by genetic factors10: the LYPLAL1 gene regulates the LYPLAL1 in adipose tissue in the same way as triglyceride lipase11,12; APOC3 inhibits lipoprotein lipase, hepatic lipase, and promotes the uptake of triglyceride (TG)13; manganese superoxide dismutase (Mn-SOD) is a scavenger of free radicals in the body, which can defend against free radicals attacking unsaturated fatty acids in biofilms and prevent lipid peroxidation14. All these genetic factors influence the catabolism and metabolism of body lipids by some mechanism.
Coal miners are more prone to occupational stress (OS) due to their prolonged exposure to a fast-paced and closed working environment15. Together with the presence of certain other specific occupational factors, they have a higher prevalence of dyslipidemia than the general population16. At present, we have not found any reports of association between OS and lipid-related genes. The Genome-Wide Association Study has reported that only a small proportion of dyslipidemia can be explained by lipid metabolism-related loci17,18,19. The development of dyslipidemia is usually the result of the interplay of multiple genes and factors, and most of the current studies only focus on environmental or genetic factors, while few studies have reported the effects of OS and gene interactions on dyslipidemia. Therefore, in this study, we selected rs12137855 in the LYPLAL1 gene, rs2854116 in the APOC3 gene and rs4880 in the SOD2 gene to investigate the association of three gene polymorphism, OS and their interaction with dyslipidemia. To provide clues for an in-depth understanding of the etiology and mechanism of dyslipidemia.
Methods
Study design and participants
We used a case–control study design. Cases were selected from 445 Chinese Han miners who participated in occupational health checkups diagnosed with dyslipidemia in a Chinese coal mine enterprise from July to September 2020. Inclusion criteria for the case group: ① those with dyslipidemia; ② length of service ≥ 1 year; exclusion criteria: ① those with diabetes, severe cardiovascular disease, chronic hepatitis or cirrhosis, or malignant tumors; ② those with incomplete questionnaires; ③ those without blood samples. Inclusion criteria for the control group: ① non-dyslipidemia coal miners who participated in the physical examination during the same period; ② length of service ≥ 1 year20. Exclusion criteria were the same as those for the case group. Two groups were matched according to age and gender, and 445 healthy controls were finally included. The study was approved by the Ethics Committee of North China University of Science and Technology (No. 15006), and all study subjects had given informed consent.
Survey content
Our investigators were strictly and uniformly trained to conduct a one-on-one questionnaire survey of coal miners to collect the following information: ① age, gender, length of service, education level, marital status, monthly household income, smoking and alcohol consumption, eating behavior, sleep quality (used Athens Insomnia Scale21), physical activity level, and shift work; ② OS: used the Chinese version of the Job Content Questionnaire (JCQ) developed by Yan Sha et al. (Cronbach 's α = 0. 74)22; ③ physical examination: height, weight, blood pressure. After participants fasted for 12 h, venous blood was drawn from 8:00 to 9:30 am the next day, and TG, total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), and high density lipoprotein-cholesterol (HDL-C) were measured by the autoanalyzer (type BS-400; Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China). Serum TC, TG, HDL-C, and LDL-C levels were determined using commercially available enzymatic assay kits.
Variables explanation
The diagnostic criteria for dyslipidemia in this study were meeting one of TC ≥ 6.2 mmol/L, TG ≥ 2.3 mmol/L, LDL-C ≥ 4.1 mmol/L, HDL-C < 1.0 mmol/L or being treated after diagnosis23. The JCQ covers 3 dimensions (5 items), job autonomy (9 items), and social support (8 items), with a total of 22 items. OS was evaluated by using the Likert 4-point scale, and each item was scored from 1 to 4. OS was evaluated by using the job demand-control ratio (D/C ratio), which was determined as OS if the D/C ratio was ≥ 1 and non-OS if the D/C ratio was < 1. The higher the D/C ratio, the higher the degree of OS.
Smoking was defined as ≥ 1 cigarette per day and ≥ 6 months of continuous smoking. Drinking was defined as drinking at least 2 times per week with at least 50 g of ethanol intake per occasion for ≥ 1 year. Dietary behavior was assigned according to the Dietary Approaches to Stop Hypertension (DASH) model24. Physical activity levels were grouped using the International Physical Activity Questionnaire assignment criteria25. Body Mass Index (BMI) was the ratio of body weight (kg) to height squared (m2). Hypertension was defined as a current systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or being treated with antihypertensive therapy. Hyperuricemia (HUA) was defined as a uric acid level ≥ 420 μmol/L in men and ≥ 357 μmol/L in women26.
Genomic DNA extraction and typing
In this study, the genomic DNA was extracted using the DNA extraction kit from Tiangen Biochemical Technology Co. We used Sequenom Genotyping Tools and Mass ARRAY Assay Design 3.1 software to design polymerase chain reaction (PCR) amplification primers and single-base extension primers for the single nucleotide polymorphism (SNP) to be tested. Gene polymorphism was detected by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Technique. See Table 1 for SNP loci information.
Statistical methods
Data for measures were described and compared between groups using x ± s and t test when the data obeyed normal distribution, otherwise M (P25, P75) and rank sum test were used. Statistical data were expressed as rates or composition ratios and compared between groups using Pearson x2 test. For all SNP loci, the Hardy–Weinberg equilibrium (HWE) test was used to determine whether the control study subjects were a random sample of the target population. The association between genetic models and dyslipidemia abnormalities was analyzed using SNPStats online software (https://www.snpstats.net/start.htm.), and Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) were used for optimal model selection. Andersson additive interaction model27 and logistic regression multiplicative interaction model were used to explore the interaction between the three genes and OS, and Generalized-Multifactor-Dimensionality-Reduction (GMDR) model was used to analyze the existence of gene–gene and gene-OS interactions with dyslipidemia. The test level α = 0.05 (both sides). The above statistical analysis was processed and analyzed using IBM SPSS 23.0 and GMDR 0.9 software.
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of North China University of Science and Technology (NO.15006). All individuals in the study signed a paper version of the informed consent.
Results
Comparison of the basic characteristics and health status of the two groups
The mean age of the study subjects included in this study was 40.24 ± 7.47 years. There were 850 males and 40 females. The basic characteristics and physical health status of the study subjects were compared between the two groups, and we found that the differences in smoking, drinking, physical activity level, DASH diet score, BMI, hypertension, shift work, sleep quality, HUA, and OS were statistically significant in the case and control groups (P < 0.05). The differences in age, gender, length of service, education level, marital status, and monthly household income of the study subjects were not statistically significant in the two groups. As shown in Table 2 (at the end of the article).
The logistic regression analysis of OS and dyslipidemia
In the logistic regression analysis of OS and dyslipidemia, model 1 adjusted only for education, marital status, and monthly household income. The results showed that the risk of dyslipidemia in the OS group was 1.76 times higher than that in the non-OS group (OR = 1.76, 95% CI 1.35–2.31). Model 2 further adjusted for lifestyle indicators based on model 1: smoking, drinking, physical activity level, DASH diet score, sleep quality, and shift work. We found an enhanced association between OS and dyslipidemia, with the risk of dyslipidemia in the OS group being 2.00 times higher than that in the non-OS group (OR = 2.00, 95% CI 1.48–2.71). Model 3 further adjusted for health status indicators: BMI, hypertension, and HUA on the basis of model 2. The results were consistent with model 1 and model 2. The differences of all three models were statistically significant (P < 0.001). As shown in Table 3.
Association of three genetic polymorphism with dyslipidemia
The HWE test for the control group
The HWE test results for the three gene polymorphic loci in the control group showed that the rs12137855 in the LYPLAL1 and rs2854116 in the APOC3 conformed to the HWE law (P > 0.05) and were well represented; but the rs4880 in the SOD2 did not conform to the law. As shown in Table 4.
Association of gene polymorphism with dyslipidemia
Due to the low frequency of the rs12137855 in the LYPLAL1 T allele in the population, mutant homozygous genotype TT at this locus was not observed in this study. Using wild homozygous type CC as the reference group, we did not find an association between the rs12137855 locus polymorphism and dyslipidemia in coal miners. However, in this analysis we found a higher risk of dyslipidemia in the co-dominant model of rs2854116 in the APOC3 in those carrying the CC genotype than in those carrying the TT genotype (OR = 1.59, 95% CI 1.03–2.45), but the test did not reach a significant level. In the dominant model, those carrying the CT/CC genotype had a statistically significant higher risk compared with those carrying the TT genotype (OR = 1.39, 95% CI 1.01–1.91). The results of the co-dominant model of rs4880 in the SOD2 showed that coal miners carrying the mutant homozygous type GG had a reduced risk of disease (OR = 0.27, 95% CI 0.11–0.64), using the wild homozygous type AA as the reference group. In the recessive model, those carrying the GG genotype had a significantly lower risk of dyslipidemia compared to those carrying the AA/AG genotype (OR = 0.28, 95% CI 0.12–0.67). The differences between the above models were statistically significant, and combining AIC and BIC, the recessive model was the optimal model among the four models. The results are shown in Table 5.
Association of OS-gene interactions with dyslipidemia
The multiplicative interaction of OS-gene
A cross-classification interaction analysis was performed between OS and various genotypes of the three genes. The group non-OS and CC genotype at the rs12137855 was used as the reference group, the results showed a reduced risk of dyslipidemia in those with OS and CC genotype (OR = 0.50, 95% CI 0.36–0.69) after correcting for potential confounders. Using the non-OS group with TT genotype at rs2854116 as the reference group, the risk of dyslipidemia was reduced in OS with TT genotype (OR = 0.40, 95% CI 0.23–0.68) and CT genotype (OR = 0.60, 95% CI 0.37–0.97). Using non-OS and the rs4880 locus AA genotype as a reference, we found that the risk of dyslipidemia was reduced in miners with OS and carrying all three genotypes: AA genotype (OR = 0.51, 95% CI 0.36–0.74), AG genotype (OR = 0.45, 95% CI 0.27–0.73), and GG genotype (OR = 0.11, 95% CI 0.04–0.37), and the strength of the association gradually increased. However, we did not find a multiplicative interaction between OS and LYPLAL1, APOC3, and SOD2 (Pinteraction > 0.05). The results are shown in Table 6.
The additive interaction of OS-gene
The Andersson additive interaction model was used in this study to analyze the additive interaction of OS-gene. Since the dominant model at locus rs2854116 is the optimal model and locus rs4880 is the recessive model, we chose the corresponding model in further analysis. Using the Excel template provided by Andersson et al. the Relative Excess Risk of Interaction (RERI) and Attributable Proportion of Interaction (AP) were calculated and the results showed that the 95% CI for RERI all included 0. Therefore, it cannot yet be assumed that OS and the three genetic polymorphisms exist based on the additive model of interaction. The results are shown in Table 7.
GMDR model of gene–gene and os-gene interactions and dyslipidemia risk
To analyze the possible higher-order interactions among LYPLAL1, APOC3, and SOD2, the GMDR model was used to analyze the association between gene–gene interactions and dyslipidemia in coal miners. After adjusting for relevant variables, it was found that the three-factor (rs12137855-rs2854116-rs4880) model had high testing balance accuracy and cross-validation consistency, but the model test results did not reach a statistically significant level (P > 0.05), and the interaction between the three genes could not yet be considered to exist. See Table 8.
However, we analyzed the OS-gene interaction based on the GMDR model and found that the single-factor model (OS), the three-factor model (rs2854116-rs4880-OS) and the four-factor (rs12137855-rs2854116-rs4880-OS) model had the greatest cross-validation consistency, and the results of the three model tests were statistically significant. Since the testing balance accuracy of the four-factor model was the highest, the best model was the four-factor interaction model. As shown in Table 9.
Discussion
With the continuous development and progress of society, the traditional medical model has changed. The focus of research on risk factors for chronic noncommunicable diseases is no longer limited to traditional factors, but is gradually including psychosocial factors as well. This is why OS has started to receive a lot of attention from researchers. In this study, OS was found to be a risk factor for dyslipidemia in coal miners by logistic regression analysis, which is consistent with the conclusions reached by some researchers28,29. The mechanism by which OS affects lipid metabolism has not been elucidated, and two hypotheses are mainly considered. One is that work stress affects the sympathetic-adrenal-medullary and hypothalamic–pituitary–adrenal axes of the body, which stimulates increased adrenaline secretion and leads to abnormal lipid metabolism30. The other is the indirect behavioral pathway, where being under prolonged stress may alter the individual's perception of need and can produce undesirable behavioral patterns such as smoking and drinking, which can lead to dyslipidemia. The health status of miners affects the national economy to a certain extent, so their physical and mental health should attract our attention.
The LYPLAL1 gene encodes a protein with sequence similarity to human acyl protein thioesterasesl and is found in adipose tissue. It was initially widely studied as a genetic susceptibility gene for obesity and type II diabetes, and later researchers found that its polymorphism were also associated with atherosclerosis and nonalcoholic fatty liver31,32,33,34. This is due to the fact that LYPLAL1 gene possesses triglyceride lipase activity, which may be involved in the process of inhibiting TG degradation, thus affecting lipolysis and metabolism in the body11,12,35. However, studies on the role of LYPLAL1 gene in lipid metabolism are still controversial36. In this study, 890 coal miners were recruited, including 445 each from patients with dyslipidemia and healthy control populations. We analyzed the association of rs12137855 polymorphism with dyslipidemia, and no association was found between the findings. However, we performed cross-classification interaction analysis between OS and rs12137855 polymorphism and showed that the CC genotype of this locus in OS population reduced the risk of dyslipidemia, suggesting a combined effect between the two. Because the frequency of the T allele at this locus is low in the Chinese Han population and the TT genotype was not observed in the subjects included in this study, the association of the rs12137855 s polymorphism with dyslipidemia needs to be further investigated.
The APOC3 gene belongs to the APO protein family and is mainly found in celiac particles and very low density lipoproteins (VLDL). It is involved in VLDL/LDL metabolism, inhibits lipoprotein esterase activity and reduces TG catabolism37. An animal model noted that TG levels were significantly increased in APOC3 overexpressing transgenic mice38. A study on the association of rs2854116 locus polymorphism with metabolic syndrome found that the frequency of C allele was significantly higher in patients with metabolic syndrome than in non-metabolic syndrome patients, and that C allele carriers had increased TG and HDL-C levels compared to wild genotype carriers, which is similar to the results of our study39. The rs2854116 in the APOC3 carries a significantly increased risk of CC/CT genotype compared with those carrying TT genotype, suggesting that the C allele of rs2854116 locus may be associated with the development of dyslipidemia. We further analyzed its interaction with OS and found that there was a combined effect of OS and rs2854116 locus: those with OS and TT/CT genotype had a lower risk of dyslipidemia than those with non-OS and TT genotype.
Mn-SOD can play an important role in maintaining the dynamic balance of superoxide anion radical production and elimination in the organism by scavenging superoxide anion radicals produced in vivo14. Recent studies have pointed out that rs4880 in the SOD2 mutation can lead to reduced Mn-SOD activity and is closely associated with diabetes, atherosclerosis, coronary heart disease, and tumorigenesis40. However, there are few studies on its association with dyslipidemia, and the mechanism of which has not been elucidated. In our study, we found that rs4880 polymorphism was associated with dyslipidemia, and the risk of dyslipidemia was significantly lower in those carrying AG/GG genotype, suggesting that the G allele may be a protective factor for dyslipidemia. In the analysis of the interaction between OS and SOD2, it was found that those carrying all three genotypes in the OS group had a reduced risk of dyslipidemia compared to the non-OS group. It is suggested that there is a combined effect of rs4880 and OS. Since the distribution of the rs4880 in the control group of the present study subjects did not conform to the HWE test. Therefore, the population representation of this study is limited, and the association between rs4880 and dyslipidemia needs to be further investigated.
In addition, the results of the analysis of interactions in this study did not reveal any interaction between OS-rs12137855, OS-rs2854116, and OS-rs4880 based on multiplicative or additive models, but higher-order interactions between the three genes and OS were found by the GMDR model. Due to the specificity of the study population, the women included in this study and the sample size were small, resulting in a limited population representation. Also, this study only explored the relationship between the three genes and dyslipidemia and did not delve into the association between them and the components of dyslipidemia. Further studies on the relationship between other related genes, OS and dyslipidemia are needed.
Conclusions
This study uses OS and genes (LYPLAL1, APOC3 and SOD2) as research variables, and explores their association with dyslipidemia in coal workers from the perspective of the interaction between environment and genetics. The results show that dyslipidemia in coal workers was related to OS and genetic factors. Through this study, we revealed the dual regulation of environmental factors and genetic factors on dyslipidemia. At the same time, this study provides clues for understanding the etiology and mechanism of dyslipidemia.
Data availability
Data are available upon reasonable request. The datasets generated and analyzed during the current study are not publicly available due other analyses are proceeding but are available from the corresponding author on reasonable request.
Abbreviations
- OS:
-
Occupational stress
- TG:
-
Triglyceride
- Mn-SOD:
-
Manganese superoxide dismutase
- JCQ:
-
The job content questionnaire
- TC:
-
Total cholesterol
- LDL-C:
-
Low density lipoprotein-cholesterol
- HDL-C:
-
High density lipoprotein-cholesterol
- D/C ratio:
-
The job demand-control ratio
- DASH:
-
The dietary approaches to stop hypertension
- BMI:
-
Body mass index
- HUA:
-
Hyperuricemia
- PCR:
-
Polymerase chain reaction
- SNP:
-
The single nucleotide polymorphism
- HWE:
-
The Hardy–Weinberg equilibrium
- AIC:
-
Akaike information criterion
- BIC:
-
Bayesian information criterion
- GMDR:
-
Generalized-multifactor-dimensionality-reduction
- RERI:
-
The relative excess risk of interaction
- AP:
-
Attributable proportion of interaction
- VLDL:
-
Very low density lipoproteins
References
Chapman, M. J., Zamorano, J. L. & Parhofer, K. G. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid [J]. Pharmacol. Ther. 237, 108172 (2022).
Fenwick, P. H. et al. Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions [J]. Crit. Rev. Food Sci. Nutr. 59(13), 2028–2039 (2019).
Grandhi, G. R. et al. Interplay of coronary artery calcium and risk factors for predicting CVD/CHD mortality: The CAC consortium [J]. JACC. Cardiovasc. Imaging 13(5), 1175–1186 (2020).
Zhang, M. et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults [J]. Int. J. Cardiol. 260, 196–203 (2018).
Kuo, W. C. et al. The association between psychological stress and metabolic syndrome: A systematic review and meta-analysis [J]. Obes. Rev. 20(11), 1651–1664 (2019).
Roche, M. Changing multicultural guidelines: Clinical and research implications for evidence-based psychotherapies [J]. Prof. Psychol. Res. Pract. 52(2), 1 (2021).
Park, J. H. et al. Epigenetic modification by dietary factors: Implications in metabolic syndrome [J]. Mol. Aspects Med. 54, 58–70 (2017).
Stone, N. J. et al. Comparing primary prevention recommendations: a focused look at United States and European guidelines on dyslipidemia [J]. Circulation 141(14), 1117–1120 (2020).
Virani, S. S. et al. Secondary prevention for atherosclerotic cardiovascular disease: Comparing recent US and European guidelines on dyslipidemia [J]. Circulation 141(14), 1121–1123 (2020).
Yang, Y. et al. TUBB-WWOX associations between SNPs, their haplotypes, gene-gene, and gene-environment interactions and dyslipidemia [J]. Aging 13(4), 5906–5927 (2021).
Anstee, Q. M., Daly, A. K. & Day, C. P. Genetic modifiers of non-alcoholic fatty liver disease progression [J]. Biochem. Biophys. Acta. 1812(11), 1557–1566 (2011).
Tian, L. et al. Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels [J]. J. Biol. Chem. 287(18), 14718 (2012).
Wei, B. C. et al. APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster-Dyslipidemia-Single nucleotide polymorphism[J]. PeerJ 6, e6175 (2019).
Wang, Q. et al. PAH exposure is associated with enhanced risk for pediatric dyslipidemia through serum SOD reduction [J]. Environ. Int. 145, 106132 (2020).
Yi, X. et al. The relationship between occupational stress and job burnout in coal miners: Interactions between GCCR and SLC6A4 gene polymorphisms and the environment [J]. J. Affect. Disord. 297, 76–82 (2022).
Rizkiani, D. O. & Modjo, R. Physical activity: mine workers’ behavior related with metabolic syndrome [J]. Indian J. Public Health Res. Dev. 10(2), 543 (2019).
Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids [J]. Nature 466(7307), 707–713 (2010).
Asselbergs, F. W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci [J]. Am. J. Hum. Genet. 91(5), 823–838 (2012).
Peloso, G.M., Chen, J., & Sengupta, S., et al. Discovery and refinement of loci associated with lipid levels [J] (2013).
Liu, C. X. et al. Associations between TUBB-WWOX SNPs, their haplotypes, gene-gene, and gene-environment interactions and dyslipidemia [J]. Aging (Albany NY) 13(4), 5906–5927 (2021).
Li, J. et al. Sleep and CKD in Chinese adults: A cross-sectional study [J]. Clin. J. Am. Soc. Nephrol. 12(6), 885–892 (2017).
Sha, Y. et al. The validation of Chinese version of job content questionnaire in health professionals [J]. Chin. Occup. Med. 30(003), 24–27 (2003).
Vargas-santos, A. B. & Tuhina, N. C. Management of Gout and Hyperuricemia in CKD[J]. Am. J. Kidney Dis. 70(3), 422–439 (2017).
Gomez-Delgado, F. et al. Dietary habits, lipoprotein metabolism and cardiovascular disease: From individual foods to dietary patterns [J]. Crit. Rev. Food Sci. Nutr. 61(10), 1651–1669 (2021).
Zhang, S. et al. Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin chronic low-grade systemic inflammation and health cohort study [J]. Int. J. Epidemiol. 51(1), 237–249 (2022).
Giuseppe, C. et al. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study [J]. Sci. Rep. 8(1), 11529 (2018).
Andersson, T. et al. Calculating measures of biological interaction [J]. Eur. J. Epidemiol. 20(7), 575–579 (2005).
Zhang, H. et al. A cross-sectional survey on occupational stress and associated dyslipidemia among medical staff in tertiary public hospitals in Wenzhou, China [J]. Brain Behav. 11(3), e2014 (2021).
Djindjic, N. et al. Associations between the occupational stress index and hypertension, type 2 diabetes mellitus, and lipid disorders in middle-aged men and women [J]. Ann. Occup. Hygiene 56(9), 1051–1062 (2012).
Singh, V. P., Khandelwal, B. & Sherpa, N. T. Psycho-neuro-endocrine-immune mechanisms of action of yoga in type II diabetes [J]. Anc. Sci. Life 35(1), 12–17 (2015).
Wang, T. et al. Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a Chinese population [J]. Sci. Rep. 6, 20691 (2016).
Heid, I. M. et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42(11), 949–960 (2010).
Randall, J. C. et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits [J]. PLoS Genet. 9(6), 3500 (2013).
Fox, C. S. et al. Genome-Wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women [J]. PLoS Genet. 8, 2695 (2012).
Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits [J]. PLoS Genet. 7(3), e1001324 (2011).
Kitamoto, A. et al. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. Endocrine J. 61(7), 683–689 (2014).
Li, W. W. et al. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Investig. 96(6), 2601–2605 (1996).
Ito, Y. et al. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice [J]. Science 249(4970), 790–793 (1990).
Pollex, R. L. et al. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample[J]. BMC Med. Genet. 8(1), 80 (2007).
Pignataro, G. et al. Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J. 276, 46–57 (2009).
Acknowledgements
We would like to thank north China University of Science and Technology for providing a software and hardware platform and financial support to ensure the smooth progress of this research. We would also like to thank our teachers and classmates for their help and warmth in the research process.
Funding
This work was supported by the National Key R&D Program of China (No.2016YFC0900605). The funding body had no role in the study design and collection, analysis, and interpretation of data and in writing the manuscript.
Author information
Authors and Affiliations
Contributions
Design research, Y.Z.Y. and J.H.W.; methodology, Y.Y.C., Z.W.Z. and H.W.; project administration, X.L.W., Z.K.Z. and R.M.; software, Y.Z.Y. and Y.Y.C.; validation, J.H.W.; writing original draft, Y.Z.Y.; writing review, Y.Z.Y. and J.H.W.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yang, Y., Zheng, Z., Chen, Y. et al. A case control study on the relationship between occupational stress and genetic polymorphism and dyslipidemia in coal miners. Sci Rep 13, 2321 (2023). https://doi.org/10.1038/s41598-023-29491-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-29491-2
- Springer Nature Limited